循證藥學在連續(xù)性腎臟替代治療期間抗凝治療決策中的應用
發(fā)布時間:2018-08-27 06:35
【摘要】:目的:探討循證藥學在連續(xù)性腎臟替代治療(CRRT)期間抗凝藥物治療中協(xié)助實施最佳治療方案的作用。方法:以1例患者行CRRT期間出現血小板減少時抗凝藥物治療決策為例,介紹臨床藥師介入臨床,通過循證藥學方法結合臨床數據,分析高出血風險及血小板減少患者行CRRT期間選用阿加曲班抗凝治療的證據,并跟蹤其療效和安全性,對藥物治療過程進行綜合評估的相關情況。結果:分析檢索到高出血風險及血小板減少患者行CRRT期間選用阿加曲班抗凝治療的文獻共5篇,其中有1篇系統(tǒng)評價、1篇隨機對照研究、3篇列隊研究。將其最佳證據應用到該例患者的臨床實踐中并取得了較好效果,患者血小板和凝血指標改善,無出血和栓塞并發(fā)癥發(fā)生。結論:循證藥學在CRRT期間抗凝治療決策中可發(fā)揮重要作用。
[Abstract]:Objective: to investigate the role of evidence-based pharmacology in the implementation of the best therapeutic regimen in the treatment of continuous renal replacement therapy (CRRT) during anticoagulant therapy. Methods: taking one patient with thrombocytopenia during CRRT as an example, the intervention of clinical pharmacists and clinical data were introduced. To analyze the evidence of Agatripine anticoagulant therapy in patients with high risk of hemorrhage and thrombocytopenia during CRRT, and to follow up its efficacy and safety, and to evaluate the process of drug therapy. Results: a total of 5 papers were collected from the patients with high risk of hemorrhage and thrombocytopenia who were treated with Agatripine anticoagulant therapy during CRRT, including 1 systematic evaluation and 1 randomized controlled study and 3 separate studies. The best evidence was applied to the clinical practice of the patient and good results were obtained. The platelet and coagulation indexes were improved without bleeding and embolization complications. Conclusion: Evidence-based pharmacology may play an important role in anticoagulant therapy decision making during CRRT.
【作者單位】: 南京醫(yī)科大學附屬蘇州醫(yī)院藥學部;上海交通大學醫(yī)學院附屬新華醫(yī)院藥學部;
【分類號】:R459.5
本文編號:2206425
[Abstract]:Objective: to investigate the role of evidence-based pharmacology in the implementation of the best therapeutic regimen in the treatment of continuous renal replacement therapy (CRRT) during anticoagulant therapy. Methods: taking one patient with thrombocytopenia during CRRT as an example, the intervention of clinical pharmacists and clinical data were introduced. To analyze the evidence of Agatripine anticoagulant therapy in patients with high risk of hemorrhage and thrombocytopenia during CRRT, and to follow up its efficacy and safety, and to evaluate the process of drug therapy. Results: a total of 5 papers were collected from the patients with high risk of hemorrhage and thrombocytopenia who were treated with Agatripine anticoagulant therapy during CRRT, including 1 systematic evaluation and 1 randomized controlled study and 3 separate studies. The best evidence was applied to the clinical practice of the patient and good results were obtained. The platelet and coagulation indexes were improved without bleeding and embolization complications. Conclusion: Evidence-based pharmacology may play an important role in anticoagulant therapy decision making during CRRT.
【作者單位】: 南京醫(yī)科大學附屬蘇州醫(yī)院藥學部;上海交通大學醫(yī)學院附屬新華醫(yī)院藥學部;
【分類號】:R459.5
【相似文獻】
相關期刊論文 前10條
1 周楚瑤;薛凡;;阿加曲班在連續(xù)性腎臟替代治療中的療效觀察[J];東南國防醫(yī)藥;2013年06期
2 楊旭;田密;李德天;;阿加曲班在血液凈化治療中的應用[J];實用藥物與臨床;2014年06期
3 石明;程暉;劉紅燕;邱昌建;賈汝漢;;阿加曲班在中心靜脈置管誘導血液透析中的應用[J];中國中西醫(yī)結合腎病雜志;2008年07期
4 常晉;崔建軍;方琪瑋;楊躍紅;;阿加曲班對兒童血液透析抗凝療效和安全性的觀察[J];中國中西醫(yī)結合腎病雜志;2011年11期
5 韋杏;姚明超;張黎美;劉羅進;;阿加曲班與肝素在血液透析抗凝治療中作用的比較分析[J];中國中西醫(yī)結合腎病雜志;2014年02期
6 李清;李德謙;任改瑛;楊瑩;;小劑量阿加曲班在連續(xù)性血液凈化治療中的應用[J];武警醫(yī)學;2012年02期
7 趙志權;磨紅;蒙潔英;何聯(lián)義;趙奇勝;徐瑾;寧燕虹;唐喜寧;;阿加曲班與低分子肝素在連續(xù)性血液凈化治療抗凝中的對比研究[J];實用醫(yī)學雜志;2010年11期
8 董春玲;施海濤;國春玲;潘淑杰;楊慶春;于海濤;柏琳;;阿加曲班在尿毒癥高危出血患者維持性血液透析治療中的療效分析[J];實用臨床醫(yī)藥雜志;2011年21期
9 劉佳;趙君;;阿加曲班與肝素類藥物在血液透析抗凝治療中的對比研究[J];軍醫(yī)進修學院學報;2012年01期
10 ;[J];;年期
,本文編號:2206425
本文鏈接:http://www.sikaile.net/huliyixuelunwen/2206425.html
最近更新
教材專著